Organism name | Hippophae rhamnoides |
---|---|
Genus | Hippophae |
Family | Elaeagnaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Hippophae rhamnoides |
---|---|
Linked NCBI taxonomy ID | 193516 |
Linked level | species |
Family in NCBI taxonomy | Elaeagnaceae |
---|---|
ID | 25996 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00007247
![]() |
Linolenic acid
/ alpha-Linolenic acid / (Z,Z,Z)-Octadeca-9,12,15-trienoic acid |
D017962
|
22 / 5 |
![]() |
||||
C00005557
![]() |
Isorhamnetin 3-glucoside-7-rhamnoside
/ Isorhamnetin 3-O-beta-glucopyranoside-7-O-alpha-rhamnopyranoside |
No. 1 | No. 15 |
![]() |
||||
C00005539
![]() |
Isorhamnetin 3-vicianoside
|
No. 1 | No. 15 |
![]() |
||||
C00005544
![]() |
Isorhamnetin 3-sophoroside
|
No. 1 | No. 15 |
![]() |
||||
C00005548
![]() |
Narcissin
/ Isorhamnetin 3-O-rutinoside |
CHEMBL84174
CHEMBL258394 CHEMBL1711509 CHEMBL2165403 |
C031062
|
7 / 1 / 2 | No. 1 | No. 15 |
![]() |
|
C00005531
![]() |
Isorhamnetin 7-rhamnoside
|
No. 2 | No. 15 |
![]() |
||||
C00005374
![]() |
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 |
![]() |
C00001071
![]() |
Myricetin
|
CHEMBL164
|
C040015
|
78 / 70 / 56 | 39 / 2 | No. 3 | No. 15 |
![]() |
C00004635
![]() |
Isorhamnetin
/ 3'-O-Methylquercetin / 3,4',5,7-Tetrahydroxy-3'-methoxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL379064
|
C047368
|
12 / 10 / 13 | 10 / 0 | No. 3 | No. 15 |
![]() |
C00005580
![]() |
Isorhamnetin 3-sophoroside-7-rhamnoside
|
No. 5 | No. 15 |
![]() |
||||
C00004565
![]() |
Kaempferol
/ Nimbecetin / Rhamnolutein / Pelargidenolon / 5,7,4'-Trihydroxyflavonol / 3,5,7,4'-Tetrahydroxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL150
|
C006552
|
76 / 69 / 87 | 86 / 8 | No. 71 | No. 15 |
![]() |
C00003766
![]() |
delta-Carotene
|
No. 131 | No. 59 |
![]() |
||||
C00029354
![]() |
Palmitoleic acid
/ cis-Palmitoleic acid / (Z)-Palmitoleic acid |
CHEMBL453509
|
2 / 5 / 3 | No. 184 | No. 68 |
![]() |
||
C00008882
![]() |
Gallocatechin 3-O-gallate
|
CHEMBL297453
CHEMBL311663 CHEMBL126079 CHEMBL338988 CHEMBL264938 |
49 / 48 / 54 | No. 219 | No. 14 |
![]() |
||
C00002647
![]() |
Gallic acid
|
CHEMBL288114
|
D005707
|
42 / 53 / 68 | 52 / 16 | No. 817 | No. 81 |
![]() |
C00031437
![]() |
Vitamin A
|
CHEMBL986
CHEMBL1454290 CHEMBL1595345 |
28 / 26 / 26 | No. 1438 |
![]() |
|||
C00001429
![]() |
Serotonin
/ Enteramin / Enteramine / DS substance / Thrombotonin / Thrombocytin / 5-Hydroxytryptamine |
CHEMBL39
CHEMBL1628597 |
D012701
|
78 / 35 / 22 | 32 / 40 | No. 1910 | No. 4 |
![]() |
C00001179
![]() |
Vitamin C
/ L-Ascorbate / L-Ascorbic acid / (+)-Ascorbic acid |
CHEMBL196
CHEMBL1161421 |
D001205
|
104 / 58 / 50 | 254 / 98 | No. 8774 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001071 C00001179 C00001429 C00004565 C00005548 C00008882 C00031437 | 0 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001071 C00001179 C00002647 C00004565 C00004635 C00005374 C00008882 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001071 C00001179 C00001429 C00002647 C00004565 C00008882 | 0 / 3 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001071 C00001179 C00002647 C00004565 C00008882 C00031437 | 4 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001071 C00002647 C00004565 C00005374 C00008882 C00031437 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001071 C00001429 C00002647 C00008882 C00031437 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001071 C00004565 C00005374 C00005548 C00031437 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001179 C00002647 C00004565 C00005548 C00031437 | 1 / 1 |
O00255 | Menin | Unclassified protein | C00001071 C00004565 C00004635 C00008882 C00031437 | 2 / 5 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001071 C00002647 C00004565 C00005374 C00008882 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001071 C00002647 C00004635 C00005374 C00008882 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001071 C00001179 C00001429 C00004565 C00004635 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001071 C00004565 C00004635 C00008882 C00031437 | 1 / 2 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001071 C00001179 C00002647 C00008882 C00031437 | 2 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001179 C00002647 C00004565 C00008882 C00031437 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00001071 C00001179 C00004565 C00004635 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00004565 C00008882 C00029354 C00031437 | 5 / 3 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001179 C00002647 C00004565 C00031437 | 0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001071 C00004565 C00008882 C00031437 | 0 / 0 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00001071 C00004565 C00004635 C00005374 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001071 C00001179 C00001429 C00004565 | 1 / 1 |
P15121 | Aldose reductase | Enzyme | C00001071 C00002647 C00004565 C00005374 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001071 C00001179 C00001429 C00004565 | 0 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001179 C00004565 C00008882 C00031437 | 2 / 2 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001071 C00002647 C00004565 C00008882 | 1 / 1 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001071 C00002647 C00004565 C00008882 | 3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00001071 C00002647 C00004565 C00008882 | 2 / 2 |
P39748 | Flap endonuclease 1 | Enzyme | C00001071 C00004565 C00004635 C00005374 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001071 C00001179 C00001429 C00004565 | 1 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001071 C00004565 C00008882 C00031437 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001179 C00001429 C00004565 C00008882 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001071 C00001179 C00001429 C00004565 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00001179 C00002647 C00008882 C00031437 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001071 C00004565 C00005374 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001071 C00002647 C00005374 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001429 C00002647 C00008882 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001071 C00001429 C00008882 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00001071 C00004565 C00004635 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00001071 C00004565 C00005374 | 1 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00001179 C00001429 C00004565 | 4 / 2 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00001071 C00004565 C00004635 | 4 / 4 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001179 C00001429 C00002647 | 1 / 2 |
P02545 | Prelamin-A/C | Unclassified protein | C00001179 C00002647 C00004565 | 11 / 10 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00001071 C00008882 C00031437 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001071 C00001179 C00001429 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002647 C00004565 | 7 / 37 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00001429 C00002647 | 0 / 1 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00001429 C00002647 | 5 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00004565 C00031437 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001179 C00001429 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00004565 C00031437 | 0 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00002647 C00008882 | 2 / 3 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001429 C00031437 | 3 / 2 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00004565 C00004635 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00001429 C00002647 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00004565 C00031437 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00001071 C00004565 | 6 / 4 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001179 C00001429 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00001071 C00004565 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001179 C00031437 | 1 / 1 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001179 C00008882 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001179 C00008882 | 5 / 9 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001071 C00001429 | 2 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001179 C00001429 | 2 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001179 C00001429 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001071 C00004565 | 1 / 1 |
Q04760 | Lactoylglutathione lyase | Enzyme | C00001071 C00004565 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001071 C00008882 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001071 C00005374 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001179 C00001429 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00001179 C00004565 | 0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | C00001071 C00004565 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00001071 C00008882 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001429 C00002647 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00002647 C00031437 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001429 C00002647 | 1 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001179 C00001429 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001179 C00001429 | 1 / 0 |
O75496 | Geminin | Unclassified protein | C00005548 C00031437 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00001429 C00002647 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001429 C00002647 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00001179 C00008882 | 2 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001071 C00004565 | 0 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005374 C00005548 | 0 / 0 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00001071 C00004565 | 1 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00001429 C00002647 | 1 / 2 |
P54132 | Bloom syndrome protein | Enzyme | C00001071 C00008882 | 1 / 2 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00001429 C00031437 | 3 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001429 C00002647 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001071 C00004565 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00001071 C00004565 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001429 C00002647 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001179 C00004565 | 1 / 8 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00001071 C00004565 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00001071 C00004565 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001429 C00002647 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001179 C00001429 | 2 / 0 |
P14151 | L-selectin | Adhesion | C00002647 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001179 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001179 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001179 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001179 | 0 / 0 |
P13674 | Prolyl 4-hydroxylase subunit alpha-1 | Enzyme | C00001179 | 0 / 0 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | C00001071 | 1 / 1 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001179 | 0 / 0 |
P05164 | Myeloperoxidase | Enzyme | C00001429 | 1 / 2 |
Q96KS0 | Egl nine homolog 2 | Enzyme | C00001179 | 0 / 0 |
P28566 | 5-hydroxytryptamine receptor 1E | Serotonin receptor | C00001429 | 0 / 0 |
Q9GZU7 | Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 | Enzyme | C00004565 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001179 | 1 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001071 | 1 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001179 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001179 | 1 / 0 |
Q9HC97 | G-protein coupled receptor 35 | Kynurenic acid receptor | C00001071 | 0 / 0 |
P51570 | Galactokinase | Enzyme | C00008882 | 1 / 1 |
P50281 | Matrix metalloproteinase-14 | M10A | C00008882 | 0 / 0 |
P16581 | E-selectin | Adhesion | C00002647 | 0 / 0 |
P04792 | Heat shock protein beta-1 | Unclassified protein | C00004635 | 2 / 1 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001179 | 1 / 1 |
P02753 | Retinol-binding protein 4 | Secreted protein | C00031437 | 1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001179 | 0 / 0 |
Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | C00004565 | 0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | C00004565 | 0 / 0 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00001429 | 0 / 0 |
Q9NWT6 | Hypoxia-inducible factor 1-alpha inhibitor | Enzyme | C00001179 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001179 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00001429 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001179 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001179 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001179 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001179 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001179 | 0 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001429 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001179 | 0 / 1 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001179 | 0 / 0 |
P49327 | Fatty acid synthase | Transferase | C00008882 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001179 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001179 | 0 / 0 |
P78536 | Disintegrin and metalloproteinase domain-containing protein 17 | M12B | C00002647 | 1 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001179 | 1 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00004565 | 1 / 0 |
P02768 | Serum albumin | Secreted protein | C00008882 | 0 / 0 |
Q14790 | Caspase-8 | C14 | C00001071 | 2 / 1 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001179 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001179 | 0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00004565 | 0 / 1 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001179 | 1 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00005548 | 0 / 0 |
Q12791 | Calcium-activated potassium channel subunit alpha-1 | KCNM, KCa1.x | C00004565 | 1 / 1 |
P03956 | Interstitial collagenase | M10A | C00001179 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001179 | 0 / 0 |
P47898 | 5-hydroxytryptamine receptor 5A | Serotonin receptor | C00001429 | 0 / 0 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00001071 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00001071 | 3 / 1 |
Q00534 | Cyclin-dependent kinase 6 | CMGC serine/threonine protein kinase family | C00004565 | 1 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00001429 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001071 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00001071 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
P06213 | Insulin receptor | TK tyrosine-protein kinase INSR subfamily | C00001071 | 5 / 4 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001179 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001179 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001071 | 2 / 2 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001179 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001179 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001179 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001179 | 0 / 0 |
P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001429 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001179 | 1 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001179 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001179 | 0 / 0 |
P10276 | Retinoic acid receptor alpha | NR1B1 | C00031437 | 1 / 2 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001179 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001179 | 3 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 1 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001429 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00008882 | 3 / 1 |
P48039 | Melatonin receptor type 1A | Melatonin receptor | C00001429 | 0 / 0 |
P13726 | Tissue factor | Membrane receptor | C00029354 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00001071 | 2 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00004565 | 0 / 0 |
P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001429 | 1 / 1 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001179 | 1 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00001071 | 0 / 1 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00001071 | 0 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001179 | 2 / 1 |
P56817 | Beta-secretase 1 | A1A | C00008882 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001071 | 0 / 0 |
P09237 | Matrilysin | M10A | C00008882 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001179 | 2 / 2 |
P08253 | 72 kDa type IV collagenase | M10A | C00008882 | 1 / 3 |
Q9UGH3 | Solute carrier family 23 member 2 | Ascorbate | C00001179 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004565 | 2 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001071 | 1 / 1 |
P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | C00008882 | 0 / 0 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00001071 | 5 / 2 |
P04406 | Glyceraldehyde-3-phosphate dehydrogenase | Enzyme | C00002647 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00005548 | 0 / 0 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00001429 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001179 | 0 / 0 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00008882 | 1 / 1 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001179 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001179 | 1 / 0 |
P12821 | Angiotensin-converting enzyme | M2 | C00002647 | 4 / 2 |
P17252 | Protein kinase C alpha type | Alpha | C00001179 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001179 | 0 / 0 |
P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | C00001071 | 9 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001179 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001179 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001179 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001179 | 0 / 0 |
P26358 | DNA (cytosine-5)-methyltransferase 1 | Transferase | C00008882 | 2 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001179 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00008882 | 0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | C00001071 | 0 / 0 |
P49286 | Melatonin receptor type 1B | Melatonin receptor | C00001429 | 0 / 1 |
P11387 | DNA topoisomerase 1 | Isomerase | C00001071 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002647 | 1 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00008882 | 1 / 1 |
P37059 | Estradiol 17-beta-dehydrogenase 2 | Enzyme | C00004565 | 0 / 0 |
P04746 | Pancreatic alpha-amylase | Hydrolase | C00001179 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001179 | 0 / 0 |
P98170 | E3 ubiquitin-protein ligase XIAP | Other cytosolic protein | C00004565 | 1 / 1 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001179 | 0 / 0 |
Q15046 | Lysine--tRNA ligase | Enzyme | C00001071 | 2 / 1 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002647 | 3 / 0 |
Q13639 | 5-hydroxytryptamine receptor 4 | Serotonin receptor | C00001429 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00031437 | 0 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00001429 | 0 / 0 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001071 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00001429 | 0 / 0 |
P14618 | Pyruvate kinase PKM | Enzyme | C00008882 | 0 / 0 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00001429 | 1 / 0 |
P10275 | Androgen receptor | NR3C4 | C00004565 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001179 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001429 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001179 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00004565 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001179 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001179 | 1 / 1 |
P30939 | 5-hydroxytryptamine receptor 1F | Serotonin receptor | C00001429 | 0 / 0 |
O95342 | Bile salt export pump | drug | C00008882 | 2 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001179 | 0 / 1 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00001429 | 0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | C00004565 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001179 | 0 / 0 |
P48147 | Prolyl endopeptidase | S9A | C00004565 | 0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | C00008882 | 1 / 0 |
O14746 | Telomerase reverse transcriptase | Enzyme | C00008882 | 5 / 5 |
P31941 | DNA dC->dU-editing enzyme APOBEC-3A | Enzyme | C00001071 | 0 / 0 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00008882 | 0 / 7 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00002647 | 4 / 1 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00004565 | 0 / 0 |
Q9H6Z9 | Egl nine homolog 3 | Enzyme | C00001179 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001071 | 1 / 1 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00001429 | 1 / 0 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
P14061 | Estradiol 17-beta-dehydrogenase 1 | Enzyme | C00004565 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001071 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001071 | 1 / 4 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001429 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001429 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001429 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001429 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001429 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001429 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001429 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001429 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001429 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001429 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001429 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001429 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001429 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001429 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001429 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001429 | 1 / 0 |
O75751 | Solute carrier family 22 member 3 | Unclassified protein | C00001429 | 0 / 0 |
O95067 | G2/mitotic-specific cyclin-B2 | Other cytosolic protein | C00004565 | 0 / 0 |
P14635 | G2/mitotic-specific cyclin-B1 | Other cytosolic protein | C00004565 | 0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | C00004565 | 0 / 0 |
Q8WWL7 | G2/mitotic-specific cyclin-B3 | Other cytosolic protein | C00004565 | 0 / 0 |
Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00001429 | 0 / 0 |
Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00001429 | 0 / 0 |
O95264 | 5-hydroxytryptamine receptor 3B | NS | C00001429 | 0 / 0 |
A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00001429 | 0 / 0 |
P49840 | Glycogen synthase kinase-3 alpha | Gsk | C00004565 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001071 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00004565 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001071 | 2 / 1 |
Q9HCT0 | Fibroblast growth factor 22 | Unclassified protein | C00001071 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001071
C00001179
C00001429
C00002647
C00004565 |
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001071
C00001179
C00002647
C00004565
C00007247 |
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001071
C00001179
C00004565
C00004635
C00005374 |
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00001071
C00004565
C00004635
C00005374
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001071
C00001179
C00004565
C00004635
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001179
C00002647
C00004565
C00004635
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001071
C00001179
C00002647
C00004565
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001071
C00001179
C00002647
C00004565
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001179
C00001429
C00004565
C00007247
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00001071
C00001179
C00002647
C00004565
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001071
C00001429
C00002647
C00004565
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001071
C00001179
C00002647
C00004565
|
4233 | MET, AUTS9, HGFR, RCCP2, c-Met | met proto-oncogene (EC:2.7.10.1) |
C00001071
C00001179
C00004565
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001071
C00001179
C00001429
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001179
C00001429
C00002647
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00001071
C00001179
C00007247
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001071
C00001179
C00001429
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001179
C00001429
C00002647
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001179
C00001429
C00004565
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00001071
C00001179
C00004565
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001179
C00002647
C00004565
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00001071
C00002647
C00004565
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00004565
C00007247
|
4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) |
C00001179
C00002647
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001179
C00004565
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00004565
C00007247
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00002647
C00004565
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00004565
C00007247
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00004565
C00007247
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001179
C00002647
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00004565
C00004635
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00004565
C00004635
|
2203 | FBP1, FBP | fructose-1,6-bisphosphatase 1 (EC:3.1.3.11) |
C00001071
C00004565
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00001071
C00004565
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001179
C00007247
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00001179
C00002647
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001179
C00002647
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00001179
C00004565
|
4973 | OLR1, CLEC8A, LOX1, LOXIN, SCARE1, SLOX1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
C00001179
C00004635
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00001179
C00004565
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00001179
C00004635
|
3082 | HGF, DFNB39, F-TCF, HGFB, HPTA, SF | hepatocyte growth factor (hepapoietin A; scatter factor) |
C00001071
C00004565
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00001179
C00004565
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00001179
C00001429
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00004565
C00007247
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001071
C00002647
|
891 | CCNB1, CCNB | cyclin B1 |
C00001071
C00004565
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00001179
C00002647
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00001071
C00002647
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002647
C00004565
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002647
C00004565
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00001071
C00004565
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00001179
C00004565
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00001071
C00001179
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00002647
C00004565
|
397 | ARHGDIB, D4, GDIA2, GDID4, LYGDI, Ly-GDI, RAP1GN1, RhoGDI2 | Rho GDP dissociation inhibitor (GDI) beta |
C00001071
C00001179
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001179
C00001429
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001071
C00001179
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001179
C00004565
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00001179
C00004565
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00001179
C00004565
|
7161 | TP73, P73 | tumor protein p73 |
C00001071
C00004565
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001179
C00004565
|
8000 | PSCA, PRO232 | prostate stem cell antigen |
C00001071
C00004565
|
7224 | TRPC5, TRP5 | transient receptor potential cation channel, subfamily C, member 5 |
C00001179
C00002647
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00001071
C00004565
|
9540 | TP53I3, PIG3 | tumor protein p53 inducible protein 3 |
C00001071
C00004565
|
6513 | SLC2A1, DYT17, DYT18, DYT9, EIG12, GLUT, GLUT1, GLUT1DS, HTLVR, PED | solute carrier family 2 (facilitated glucose transporter), member 1 |
C00001071
C00004565
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00002647
C00004565
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004565
C00004635
|
7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00004565
C00004635
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00002647
|
7019 | TFAM, MTTF1, MTTFA, TCF6, TCF6L1, TCF6L2, TCF6L3 | transcription factor A, mitochondrial |
C00004565
|
6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa |
C00004565
|
2810 | SFN, YWHAS | stratifin |
C00004565
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00004565
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00004565
|
7352 | UCP3, SLC25A9 | uncoupling protein 3 (mitochondrial, proton carrier) |
C00004565
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00004565
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00004565
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00004565
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00004565
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00004565
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00004565
|
7402 | UTRN, DMDL, DRP, DRP1 | utrophin |
C00004565
|
8839 | WISP2, CCN5, CT58, CTGF-L | WNT1 inducible signaling pathway protein 2 |
C00004565
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00004565
|
8202 | NCOA3, ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | nuclear receptor coactivator 3 (EC:2.3.1.48) |
C00004565
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00004565
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001071
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00001071
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00001071
|
54583 | EGLN1, C1orf12, ECYT3, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2, SM20, ZMYND6 | egl-9 family hypoxia-inducible factor 1 (EC:1.14.11.29) |
C00001071
|
4502 | MT2A, MT2 | metallothionein 2A |
C00004565
|
110357 |
C00004565
|
||
4297 | KMT2A, ALL-1, CXXC7, HRX, HTRX1, MLL, MLL/GAS7, MLL1A, TET1-MLL, TRX1, WDSTS | lysine (K)-specific methyltransferase 2A (EC:2.1.1.43) |
C00004565
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00001071
|
8505 | PARG, PARG99 | poly (ADP-ribose) glycohydrolase (EC:3.2.1.143) |
C00001071
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00004565
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00004565
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00001071
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00001071
|
3043 | HBB, CD113t-C, beta-globin | hemoglobin, beta |
C00004565
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00004565
|
16 | AARS, CMT2N | alanyl-tRNA synthetase (EC:6.1.1.7) |
C00001179
|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001179
|
59272 | ACE2, ACEH | angiotensin I converting enzyme 2 (EC:3.4.17.23) |
C00001179
|
59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00001179
|
112 | ADCY6, AC6 | adenylate cyclase 6 (EC:4.6.1.1) |
C00001179
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00001179
|
248 | ALPI, IAP | alkaline phosphatase, intestinal (EC:3.1.3.1) |
C00001179
|
290 | ANPEP, APN, CD13, GP150, LAP1, P150, PEPN | alanyl (membrane) aminopeptidase (EC:3.4.11.2) |
C00001179
|
301 | ANXA1, ANX1, LPC1 | annexin A1 |
C00001179
|
335 | APOA1 | apolipoprotein A-I |
C00001179
|
9687 | GREB1 | growth regulation by estrogen in breast cancer 1 |
C00004565
|
55937 | APOM, G3a, HSPC336, NG20, apo-M | apolipoprotein M |
C00001179
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00001179
|
360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00001179
|
440 | ASNS, TS11 | asparagine synthetase (glutamine-hydrolyzing) (EC:6.3.5.4) |
C00001179
|
467 | ATF3 | activating transcription factor 3 |
C00001179
|
9212 | AURKB, AIK2, AIM-1, AIM1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5, aurkb-sv1, aurkb-sv2 | aurora kinase B (EC:2.7.11.1) |
C00001179
|
79370 | BCL2L14, BCLG | BCL2-like 14 (apoptosis facilitator) |
C00001179
|
632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein |
C00001179
|
12095 |
C00001179
|
||
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00001179
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00001179
|
699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00001179
|
768 | CA9, CAIX, MN | carbonic anhydrase IX (EC:4.2.1.1) |
C00001179
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001179
|
875 | CBS, HIP4 | cystathionine-beta-synthase (EC:4.2.1.22) |
C00001179
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00001179
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00001179
|
894 | CCND2, KIAK0002 | cyclin D2 |
C00001179
|
100133941 | CD24, CD24A | CD24 molecule |
C00001179
|
947 | CD34 | CD34 molecule |
C00001179
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00001179
|
990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 |
C00001179
|
728642 | CDK11A, CDC2L2, CDC2L3, CDK11-p110, CDK11-p46, CDK11-p58, PITSLRE, p58GTA | cyclin-dependent kinase 11A (EC:2.7.11.22) |
C00001179
|
629 | CFB, AHUS4, BF, BFD, CFAB, FB, FBI12, GBG, H2-Bf, PBF2 | complement factor B (EC:3.4.21.47) |
C00001179
|
11113 | CIT, CRIK, STK21 | citron (rho-interacting, serine/threonine kinase 21) (EC:2.7.11.1) |
C00001179
|
1264 | CNN1, SMCC, Sm-Calp | calponin 1, basic, smooth muscle |
C00001179
|
1270 | CNTF, HCNTF | ciliary neurotrophic factor |
C00001179
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00001179
|
1380 | CR2, C3DR, CD21, CR, CVID7, SLEB9 | complement component (3d/Epstein Barr virus) receptor 2 |
C00001179
|
1519 | CTSO, CTSO1 | cathepsin O (EC:3.4.22.42) |
C00001179
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00001179
|
6372 | CXCL6, CKA-3, GCP-2, GCP2, SCYB6 | chemokine (C-X-C motif) ligand 6 |
C00001179
|
4283 | CXCL9, CMK, Humig, MIG, SCYB9, crg-10 | chemokine (C-X-C motif) ligand 9 |
C00001179
|
643 | CXCR5, BLR1, CD185, MDR15 | chemokine (C-X-C motif) receptor 5 |
C00001179
|
79901 | CYBRD1, CYB561A2, DCYTB, FRRS3 | cytochrome b reductase 1 |
C00001179
|
1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) |
C00001179
|
1588 | CYP19A1, ARO, ARO1, CPV1, CYAR, CYP19, CYPXIX, P-450AROM | cytochrome P450, family 19, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001179
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00001179
|
1556 | CYP2B7P, CYP2B, CYP2B7, CYP2B7P1 | cytochrome P450, family 2, subfamily B, polypeptide 7, pseudogene |
C00001179
|
4616 | GADD45B, GADD45BETA, MYD118 | growth arrest and DNA-damage-inducible, beta |
C00004565
|
22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00001179
|
9787 | DLGAP5, DLG7, HURP | discs, large (Drosophila) homolog-associated protein 5 |
C00001179
|
54431 | DNAJC10, ERdj5, JPDI, MTHr, PDIA19 | DnaJ (Hsp40) homolog, subfamily C, member 10 |
C00001179
|
1773 | DNASE1, DNL1, DRNI | deoxyribonuclease I (EC:3.1.21.1) |
C00001179
|
1803 | DPP4, ADABP, ADCP2, CD26, DPPIV, TP103 | dipeptidyl-peptidase 4 (EC:3.4.14.5) |
C00001179
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001179
|
1908 | EDN3, ET-3, ET3, HSCR4, PPET3, WS4B | endothelin 3 |
C00001179
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00001179
|
112399 | EGLN3, HIFP4H3, HIFPH3, PHD3 | egl-9 family hypoxia-inducible factor 3 (EC:1.14.11.29) |
C00001179
|
8894 | EIF2S2, EIF2, EIF2B, EIF2beta, PPP1R67, eIF-2-beta | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa |
C00001179
|
8661 | EIF3A, EIF3, EIF3S10, P167, TIF32, eIF3-p170, eIF3-theta, p180, p185 | eukaryotic translation initiation factor 3, subunit A |
C00001179
|
8343525 |
C00001179
|
||
1973 | EIF4A1, DDX2A, EIF-4A, EIF4A, eIF-4A-I, eIF4A-I | eukaryotic translation initiation factor 4A1 (EC:3.6.4.13) |
C00001179
|
2012 | EMP1, CL-20, EMP-1, TMP | epithelial membrane protein 1 |
C00001179
|
2014 | EMP3, YMP | epithelial membrane protein 3 |
C00001179
|
2034 | EPAS1, ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73 | endothelial PAS domain protein 1 |
C00001179
|
2052 | EPHX1, EPHX, EPOX, HYL1, MEH | epoxide hydrolase 1, microsomal (xenobiotic) (EC:3.3.2.9) |
C00001179
|
2053 | EPHX2, CEH, SEH | epoxide hydrolase 2, cytoplasmic (EC:3.3.2.10 3.1.3.76) |
C00001179
|
2058 | EPRS, EARS, GLUPRORS, PARS, QARS, QPRS | glutamyl-prolyl-tRNA synthetase (EC:6.1.1.15 6.1.1.17) |
C00001179
|
2172 | FABP6, I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP | fatty acid binding protein 6, ileal |
C00001179
|
2321 | FLT1, FLT, FLT-1, VEGFR-1, VEGFR1 | fms-related tyrosine kinase 1 (EC:2.7.10.1) |
C00001179
|
2326 | FMO1 | flavin containing monooxygenase 1 (EC:1.14.13.8) |
C00001179
|
2330 | FMO5 | flavin containing monooxygenase 5 (EC:1.14.13.8) |
C00001179
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00001179
|
2302 | FOXJ1, FKHL13, HFH-4, HFH4 | forkhead box J1 |
C00001179
|
2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) |
C00001179
|
2535 | FZD2, Fz2, fz-2, fzE2, hFz2 | frizzled family receptor 2 |
C00001179
|
50486 | G0S2, RP1-28O10.2 | G0/G1switch 2 |
C00001179
|
2580 | GAK, DNAJ26, DNAJC26 | cyclin G associated kinase (EC:2.7.11.1) |
C00001179
|
2617 | GARS, CMT2D, DSMAV, GlyRS, HMN5, SMAD1 | glycyl-tRNA synthetase (EC:6.1.1.14) |
C00001179
|
2623 | GATA1, ERYF1, GATA-1, GF-1, GF1, NF-E1, NFE1, XLANP, XLTDA, XLTT | GATA binding protein 1 (globin transcription factor 1) |
C00001179
|
2674 | GFRA1, GDNFR, GDNFRA, GFR-ALPHA-1, RET1L, RETL1, TRNR1 | GDNF family receptor alpha 1 |
C00001179
|
2744 | GLS, AAD20, GAC, GAM, GLS1, KGA | glutaminase (EC:3.5.1.2) |
C00001179
|
2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) |
C00001179
|
2877 | GPX2, GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI, GSHPx-2 | glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
C00001179
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00001179
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00001179
|
2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00001179
|
2965 | GTF2H1, BTF2, P62, TFB1, TFIIH | general transcription factor IIH, polypeptide 1, 62kDa |
C00001179
|
9843 | HEPH, CPL | hephaestin |
C00001179
|
9709 | HERPUD1, HERP, Mif1, SUP | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
C00001179
|
3098 | HK1, HK1-ta, HK1-tb, HK1-tc, HKD, HKI, HMSNR, HXK1 | hexokinase 1 (EC:2.7.1.1) |
C00001179
|
3240 | HP, BP, HP2ALPHA2, HPA1S | haptoglobin |
C00001179
|
3283 | HSD3B1, 3BETAHSD, HSD3B, HSDB3, HSDB3A, I, SDR11E1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (EC:1.1.1.145 5.3.3.1) |
C00001179
|
3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00001179
|
3309 | HSPA5, BIP, GRP78, MIF2 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
C00001179
|
3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00001179
|
3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00001179
|
3347 | HTN3, HIS2, HTN2, HTN5 | histatin 3 |
C00001179
|
3376 | IARS, IARS1, ILERS, ILRS, IRS, PRO0785 | isoleucyl-tRNA synthetase (EC:6.1.1.5) |
C00001179
|
8870 | IER3, DIF-2, DIF2, GLY96, IEX-1, IEX-1L, IEX1, PRG1 | immediate early response 3 |
C00001179
|
3488 | IGFBP5, IBP5 | insulin-like growth factor binding protein 5 |
C00001179
|
10320 | IKZF1, Hs.54452, IK1, IKAROS, LYF1, PRO0758, ZNFN1A1, hIk-1 | IKAROS family zinc finger 1 (Ikaros) |
C00001179
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00004565
|
3745 | KCNB1, DRK1, KV2.1, h-DRK1 | potassium voltage-gated channel, Shab-related subfamily, member 1 |
C00001179
|
3791 | KDR, CD309, FLK1, VEGFR, VEGFR2 | kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) |
C00001179
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00001179
|
3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) |
C00001179
|
3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 |
C00001179
|
4017 | LOXL2, LOR2, WS9-14 | lysyl oxidase-like 2 (EC:1.4.3.-) |
C00001179
|
4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) |
C00001179
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00001179
|
10892 | MALT1, IMD12, MLT, MLT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 (EC:3.4.22.-) |
C00001179
|
5606 | MAP2K3, MAPKK3, MEK3, MKK3, PRKMK3, SAPKK-2, SAPKK2 | mitogen-activated protein kinase kinase 3 (EC:2.7.12.2) |
C00001179
|
5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00001179
|
4217 | MAP3K5, ASK1, MAPKKK5, MEKK5 | mitogen-activated protein kinase kinase kinase 5 (EC:2.7.11.25) |
C00001179
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00001179
|
1734 | DIO2, 5DII, D2, DIOII, SelY, TXDI2 | deiodinase, iodothyronine, type II (EC:1.97.1.10) |
C00004565
|
37618 |
C00004565
|
||
4173 | MCM4, CDC21, CDC54, NKCD, NKGCD, P1-CDC21, hCdc21 | minichromosome maintenance complex component 4 (EC:3.6.4.12) |
C00001179
|
4224 | MEP1A, PPHA | meprin A, alpha (PABA peptide hydrolase) (EC:3.4.24.18) |
C00001179
|
4288 | MKI67, KIA, MIB-1 | marker of proliferation Ki-67 |
C00001179
|
4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00001179
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00001179
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00004565
|
983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00004565
|
4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00001179
|
4485 | MST1, D3F15S2, DNF15S2, HGFL, MSP, NF15S2 | macrophage stimulating 1 (hepatocyte growth factor-like) |
C00001179
|
11223 | MST1L, BRF-1, D1F15S1A, MSPL-7, MSPL7, MST1P9, MSTP7, MSTP9 | macrophage stimulating 1-like |
C00001179
|
4504 | MT3, GIF, GIFB, GRIF, ZnMT3 | metallothionein 3 |
C00001179
|
10797 | MTHFD2, NMDMC | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (EC:3.5.4.9 1.5.1.15) |
C00001179
|
4605 | MYBL2, B-MYB, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 |
C00001179
|
4640 | MYO1A, BBMI, DFNA48, MIHC, MYHL | myosin IA |
C00001179
|
4677 | NARS, ASNRS, NARS1 | asparaginyl-tRNA synthetase (EC:6.1.1.22) |
C00001179
|
10397 | NDRG1, CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL, NDR1, NMSL, PROXY1, RIT42, RTP, TARG1, TDD5 | N-myc downstream regulated 1 |
C00001179
|
4800 | NFYA, CBF-A, CBF-B, HAP2, NF-YA | nuclear transcription factor Y, alpha |
C00001179
|
4814 | NINJ1, NIN1, NINJURIN | ninjurin 1 |
C00001179
|
7080 | NKX2-1, BCH, BHC, NK-2, NKX2.1, NKX2A, TEBP, TITF1, TTF-1, TTF1 | NK2 homeobox 1 |
C00001179
|
4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00001179
|
2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00001179
|
8013 | NR4A3, CHN, CSMF, MINOR, NOR1, TEC | nuclear receptor subfamily 4, group A, member 3 |
C00001179
|
10956 | OS9, ERLEC2, OS-9 | osteosarcoma amplified 9, endoplasmic reticulum lectin |
C00001179
|
8974 | P4HA2 | prolyl 4-hydroxylase, alpha polypeptide II (EC:1.14.11.2) |
C00001179
|
54681 | P4HTM, EGLN4, HIFPH4, P4H-TM, PH-4, PH4, PHD4 | prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
C00001179
|
5106 | PCK2, PEPCK, PEPCK-M, PEPCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) (EC:4.1.1.32) |
C00001179
|
64714 | PDIA2, PDA2, PDI, PDIP, PDIR | protein disulfide isomerase family A, member 2 (EC:5.3.4.1) |
C00001179
|
2923 | PDIA3, ER60, ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC | protein disulfide isomerase family A, member 3 (EC:5.3.4.1) |
C00001179
|
26227 | PHGDH, 3-PGDH, 3PGDH, PDG, PGAD, PGD, PGDH, SERA | phosphoglycerate dehydrogenase (EC:1.1.1.95) |
C00001179
|
22822 | PHLDA1, DT1P1B11, PHRIP, TDAG51 | pleckstrin homology-like domain, family A, member 1 |
C00001179
|
7262 | PHLDA2, BRW1C, BWR1C, HLDA2, IPL, TSSC3 | pleckstrin homology-like domain, family A, member 2 |
C00001179
|
11145 | PLA2G16, AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-1, HREV107-3, HRSL3 | phospholipase A2, group XVI (EC:3.1.1.4 3.1.1.32) |
C00001179
|
5340 | PLG | plasminogen (EC:3.4.21.7) |
C00001179
|
5347 | PLK1, PLK, STPK13 | polo-like kinase 1 (EC:2.7.11.21) |
C00001179
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00001179
|
5376 | PMP22, CMT1A, CMT1E, DSS, GAS-3, HMSNIA, HNPP, Sp110 | peripheral myelin protein 22 |
C00001179
|
5444 | PON1, ESA, MVCD5, PON | paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00001179
|
5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) |
C00001179
|
5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 |
C00001179
|
5588 | PRKCQ, PRKCT, nPKC-theta | protein kinase C, theta (EC:2.7.11.13) |
C00001179
|
38175 |
C00001179
|
||
5702 | PSMC3, TBP1 | proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
C00001179
|
5865 | RAB3B | RAB3B, member RAS oncogene family |
C00001179
|
5870 | RAB6A, RAB6 | RAB6A, member RAS oncogene family |
C00001179
|
6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 |
C00004565
|
5889 | RAD51C, BROVCA3, FANCO, R51H3, RAD51L2 | RAD51 paralog C |
C00001179
|
25788 | RAD54B, RDH54 | RAD54 homolog B (S. cerevisiae) |
C00001179
|
1827 | RCAN1, ADAPT78, CSP1, DSC1, DSCR1, MCIP1, RCN1 | regulator of calcineurin 1 |
C00001179
|
860 | RUNX2, AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD, OSF-2, OSF2, PEA2aA, PEBP2aA | runt-related transcription factor 2 |
C00001179
|
795 | S100G, CABP, CABP1, CABP9K, CALB3 | S100 calcium binding protein G |
C00001179
|
5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00001179
|
83667 | SESN2, HI95, SES2, SEST2 | sestrin 2 |
C00001179
|
6439 | SFTPB, PSP-B, SFTB3, SFTP3, SMDP1, SP-B | surfactant protein B |
C00001179
|
6472 | SHMT2, GLYA, SHMT | serine hydroxymethyltransferase 2 (mitochondrial) (EC:2.1.2.1) |
C00001179
|
6476 | SI | sucrase-isomaltase (alpha-glucosidase) (EC:3.2.1.10 3.2.1.48) |
C00001179
|
4891 | SLC11A2, DCT1, DMT1, NRAMP2 | solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
C00001179
|
10864 | SLC22A7, NLT, OAT2 | solute carrier family 22 (organic anion transporter), member 7 |
C00001179
|
9963 | SLC23A1, SLC23A2, SVCT1, YSPL3 | solute carrier family 23 (ascorbic acid transporter), member 1 |
C00001179
|
9962 | SLC23A2, NBTL1, SLC23A1, SVCT2, YSPL2 | solute carrier family 23 (ascorbic acid transporter), member 2 |
C00001179
|
79677 | SMC6, SMC-6, SMC6L1, hSMC6 | structural maintenance of chromosomes 6 |
C00001179
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00001179
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00001179
|
6657 | SOX2, ANOP3, MCOPS3 | SRY (sex determining region Y)-box 2 |
C00001179
|
6667 | SP1 | Sp1 transcription factor |
C00001179
|
6670 | SP3, SPR2 | Sp3 transcription factor |
C00001179
|
6671 | SP4, HF1B, SPR-1 | Sp4 transcription factor |
C00001179
|
6678 | SPARC, ON | secreted protein, acidic, cysteine-rich (osteonectin) |
C00001179
|
6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 |
C00001179
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00001179
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00001179
|
9262 | STK17B, DRAK2 | serine/threonine kinase 17b (EC:2.7.11.1) |
C00001179
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00004565
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00004565
|
20888 |
C00001179
|
||
6822 | SULT2A1, DHEA-ST, DHEAS, HST, ST2, ST2A1, ST2A3, STD, hSTa | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 (EC:2.8.2.14) |
C00001179
|
6876 | TAGLN, SM22, SMCC, TAGLN1, WS3-10 | transgelin |
C00001179
|
6897 | TARS, ThrRS | threonyl-tRNA synthetase (EC:6.1.1.3) |
C00001179
|
6901 | TAZ, BTHS, CMD3A, EFE, EFE2, G4.5, LVNCX, Taz1 | tafazzin |
C00001179
|
7018 | TF, PRO1557, PRO2086, TFQTL1 | transferrin |
C00001179
|
7032 | TFF2, SML1, SP | trefoil factor 2 |
C00001179
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00001179
|
7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 |
C00001179
|
4071 | TM4SF1, H-L6, L6, M3S1, TAAL6 | transmembrane 4 L six family member 1 |
C00001179
|
164656 | TMPRSS6, IRIDA | transmembrane protease, serine 6 |
C00001179
|
4982 | TNFRSF11B, OCIF, OPG, TR1 | tumor necrosis factor receptor superfamily, member 11b |
C00001179
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00001179
|
11257 | TP53TG1, LINC00096, NCRNA00096, P53TG1, P53TG1-D, TP53AP1 | TP53 target 1 (non-protein coding) |
C00001179
|
57761 | TRIB3, C20orf97, NIPK, SINK, SKIP3, TRB3 | tribbles pseudokinase 3 |
C00001179
|
9322 | TRIP10, CIP4, HSTP, STOT, STP | thyroid hormone receptor interactor 10 |
C00001179
|
239 | ALOX12, 12-LOX, 12S-LOX, LOG12 | arachidonate 12-lipoxygenase (EC:1.13.11.31) |
C00004565
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00001179
|
7319 | UBE2A, HHR6A, MRXS30, MRXSN, RAD6A, UBC2 | ubiquitin-conjugating enzyme E2A (EC:6.3.2.19) |
C00001179
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00001179
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00001179
|
7428 | VHL, HRCA1, RCA1, VHL1, pVHL | von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
C00001179
|
55350 | VNN3, HSA238982 | vanin 3 |
C00001179
|
7443 | VRK1, PCH1, PCH1A | vaccinia related kinase 1 (EC:2.7.11.1) |
C00001179
|
7453 | WARS, GAMMA-2, IFI53, IFP53 | tryptophanyl-tRNA synthetase (EC:6.1.1.2) |
C00001179
|
10352 | WARS2, TrpRS | tryptophanyl tRNA synthetase 2, mitochondrial (EC:6.1.1.2) |
C00001179
|
25937 | WWTR1, TAZ | WW domain containing transcription regulator 1 |
C00001179
|
7512 | XPNPEP2, APP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound (EC:3.4.11.9) |
C00001179
|
7515 | XRCC1, RCC | X-ray repair complementing defective repair in Chinese hamster cells 1 |
C00001179
|
7718 | ZNF165, CT53, LD65, ZSCAN7 | zinc finger protein 165 |
C00001179
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00002647
|
545 | ATR, FCTCS, FRP1, MEC1, SCKL, SCKL1 | ataxia telangiectasia and Rad3 related (EC:2.7.11.1) |
C00002647
|
613 | BCR, ALL, BCR1, CML, D22S11, D22S662, PHL | breakpoint cluster region (EC:2.7.11.1) |
C00002647
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002647
|
898 | CCNE1, CCNE | cyclin E1 |
C00002647
|
998 | CDC42, CDC42Hs, G25K | cell division cycle 42 |
C00002647
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002647
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00002647
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00002647
|
2551 | GABPA, E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A, RCH04A07 | GA binding protein transcription factor, alpha subunit 60kDa |
C00002647
|
2885 | GRB2, ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2 | growth factor receptor-bound protein 2 |
C00002647
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00004565
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002647
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00002647
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00002647
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00002647
|
4793 | NFKBIB, IKBB, TRIP9 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
C00002647
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00002647
|
5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00002647
|
19412 |
C00002647
|
||
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00002647
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00002647
|
6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00002647
|
9252 | RPS6KA5, MSK1, MSPK1, RLPK | ribosomal protein S6 kinase, 90kDa, polypeptide 5 (EC:2.7.11.1) |
C00002647
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002647
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00002647
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00002647
|
2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00001429
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00001429
|
3352 | HTR1D, 5-HT1D, HT1DA, HTR1DA, HTRL, RDC4 | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
C00001429
|
3356 | HTR2A, 5-HT2A, HTR2 | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
C00001429
|
3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00001429
|
9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00001429
|
3363 | HTR7, 5-HT7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
C00001429
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001429
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00001429
|
4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00001429
|
6570 | SLC18A1, CGAT, VAT1, VMAT1 | solute carrier family 18 (vesicular monoamine transporter), member 1 |
C00001429
|
6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00001429
|
85413 | SLC22A16, CT2, FLIPT2, OAT6, OCT6, OKB1, dJ261K5.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
C00001429
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001429
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001429
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001429
|
6814 | STXBP3, MUNC18-3, MUNC18C, PSP, UNC-18C | syntaxin binding protein 3 |
C00001429
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001429
|
7166 | TPH1, TPRH, TRPH, TPH | tryptophan hydroxylase 1 (EC:1.14.16.4) |
C00001429
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00001429
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00001429
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00001429
|
8647 | ABCB11, ABC16, BRIC2, BSEP, PFIC-2, PFIC2, PGY4, SPGP | ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
C00007247
|
1374 | CPT1A, CPT1, CPT1-L, L-CPT1 | carnitine palmitoyltransferase 1A (liver) (EC:2.3.1.21) |
C00007247
|
1591 | CYP24A1, CP24, CYP24, HCAI, P450-CC24 | cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126) |
C00007247
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00007247
|
3992 | FADS1, D5D, FADS6, FADSD5, LLCDL1, TU12 | fatty acid desaturase 1 (EC:1.14.19.-) |
C00007247
|
3827 | KNG1, BDK, BK, KNG | kininogen 1 |
C00007247
|
9971 | NR1H4, BAR, FXR, HRR-1, HRR1, RIP14 | nuclear receptor subfamily 1, group H, member 4 |
C00007247
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00007247
|
100136658 |
C00007247
|
||
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00007247
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00007247
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00007247
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00007247
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#612376 | Acute promyelocytic leukemia; apl |
P10276
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 P47869 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#609135 | Aplastic anemia |
O14746
|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
#600807 | Asthma, susceptibility to |
Q13093
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#114480 | Breast cancer |
P42336
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#607271 | Caspase 8 deficiency |
Q14790
|
#604121 | Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant; adcadn |
P26358
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#606595 | Charcot-marie-tooth disease, axonal, type 2f; cmt2f |
P04792
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#613641 | Charcot-marie-tooth disease, recessive intermediate b; cmtrib |
Q15046
|
#605479 | Cholestasis, benign recurrent intrahepatic, 2; bric2 |
O95342
|
#601847 | Cholestasis, progressive familial intrahepatic, 2; pfic2 |
O95342
|
#114500 | Colorectal cancer; crc |
P18054
P42336 Q14191 |
#612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
#615108 | Cowden syndrome 5; cws5 |
P42336
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#613916 | Deafness, autosomal recessive 89; dfnb89 |
Q15046
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#610549 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans |
P06213
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P06213
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#246200 | Donohue syndrome |
P06213
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#613989 | Dyskeratosis congenita, autosomal dominant, 2; dkca2 |
O14746
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
P18054 |
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#230200 | Galactokinase deficiency |
P51570
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#609446 | Generalized epilepsy and paroxysmal dyskinesia; gepd |
Q12791
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
P37231 |
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#614519 | Hemorrhage, intracerebral, susceptibility to; ich |
P12821
|
#114550 | Hepatocellular carcinoma |
P08581
P42336 |
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
#609968 | Hyperinsulinemic hypoglycemia, familial, 5; hhf5 |
P06213
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#614328 | Inflammatory skin and bowel disease, neonatal; nisbd |
P78536
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#182000 | Keratosis, seborrheic |
P42336
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 Q14790 |
#300635 | Lymphoproliferative syndrome, x-linked, 2; xlp2 |
P98170
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
#603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#615134 | Melanoma, cutaneous malignant, susceptibility to, 9; cmm9 |
O14746
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#612624 | Microvascular complications of diabetes, susceptibility to, 3; mvcd3 |
P12821
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#254600 | Myeloperoxidase deficiency; mpod |
P05164
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#608634 | Neuronopathy, distal hereditary motor, type iib; hmn2b |
P04792
|
#614116 | Neuropathy, hereditary sensory, type ie; hsn1e |
P26358
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
P42336 |
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#262190 | Pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities |
P06213
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614742 | Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1; pfbmft1 |
O14746
|
#178500 | Pulmonary fibrosis, idiopathic; ipf |
O14746
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#267430 | Renal tubular dysgenesis; rtd |
P12821
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#615147 | Retinal dystrophy, iris coloboma, and comedogenic acne syndrome; rdccas |
P02753
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
%612223 | Stature quantitative trait locus 11; stqtl11 |
Q00534
|
#601367 | Stroke, ischemic |
P12821
P16109 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00764 | Cri du chat syndrome |
O14746
(related)
|
H01132 | Aplastic anemia (AA) |
O14746
(related)
|
H01299 | Idiopathic pulmonary fibrosis |
O14746
(related)
|
H00022 | Bladder cancer |
O14746
(marker)
P00533 (related) P04626 (related) P04637 (related) |
H00024 | Prostate cancer |
O14746
(marker)
P10275 (related) |
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) Q16790 (marker) |
H00624 | Familial cholestasis |
O95342
(related)
|
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) P10415 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) P10415 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P10415 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) Q15046 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
P11511 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P42336 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P10415 (related) P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
P10415 (related) |
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
P10415 (related) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00856 | Distal hereditary motor neuropathies (dHMN) |
P04792
(related)
|
H00101 | Other phagocyte defects |
P05164
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P05164
(marker)
P10276 (related) P10276 (marker) P36888 (related) Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00719 | Leprechaunism |
P06213
(related)
|
H00942 | Rabson-Mendenhall syndrome |
P06213
(related)
|
H01228 | Insulin-resistant diabetes mellitus with acanthosis nigricans (IRAN) |
P06213
(related)
|
H01267 | Familial hyperinsulinemic hypoglycemia (HHF) |
P06213
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00516 | Isolated orofacial clefts |
P10276
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00083 | Allograft rejection |
P12821
(related)
|
H00575 | Renal tubular dysgenesis |
P12821
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
Q92887 (related) |
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H00769 | Hyperekplexia |
P23415
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
P49286 (related) |
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00070 | Galactosemia |
P51570
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00107 | Other well-defined immunodeficiency syndromes |
P98170
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H01258 | Generalized epilepsy and paroxysmal dyskinesia (GEPD) |
Q12791
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00108 | Autoimmune lymphoproliferative syndromes (ALPS) |
Q14790
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D009203 | Myocardial Infarction |
C00001071
C00001179 C00002647 |
D009422 | Nervous System Diseases |
C00001179
C00001429 C00007247 |
D012640 | Seizures |
C00001179
C00001429 |
D002318 | Cardiovascular Diseases |
C00004565
C00001179 |
D006943 | Hyperglycemia |
C00004565
C00002647 |
D020521 | Stroke |
C00001179
C00001429 |
D013276 | Stomach Ulcer |
C00001179
C00001429 |
D013226 | Status Epilepticus |
C00001179
C00001429 |
D010146 | Pain |
C00005374
C00001429 |
D009202 | Cardiomyopathies |
C00004565
C00001179 |
D001943 | Breast Neoplasms |
C00004565
C00001179 |
D007249 | Inflammation |
C00001429
C00007247 |
D009336 | Necrosis |
C00001179
C00001429 |
D009135 | Muscular Diseases |
C00001179
C00001429 |
D007022 | Hypotension |
C00001179
C00001429 |
D006973 | Hypertension |
C00001179
C00001429 |
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001179
C00007247 |
D002375 | Catalepsy |
C00001179
C00001429 |
D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
C00002647
|
D001424 | Bacterial Infections |
C00001179
|
D001766 | Blindness |
C00001179
|
D001847 | Bone Diseases |
C00001179
|
D001927 | Brain Diseases |
C00001179
|
D002545 | Brain Ischemia |
C00001179
|
D002277 | Carcinoma |
C00001179
|
D006528 | Carcinoma, Hepatocellular |
C00001179
|
D018376 | Cardiovascular Abnormalities |
C00001179
|
D000756 | Anemia, Sideroblastic |
C00001179
|
D002386 | Cataract |
C00001179
|
D002471 | Cell Transformation, Neoplastic |
C00001179
|
D002607 | Charcot-Marie-Tooth Disease |
C00001179
|
D002869 | Chromosome Aberrations |
C00001179
|
D003139 | Common Cold |
C00001179
|
D020918 | Complex Regional Pain Syndromes |
C00001179
|
D003327 | Coronary Disease |
C00001179
|
D003681 | Dehydration |
C00001179
|
D003924 | Diabetes Mellitus, Type 2 |
C00001179
|
D003928 | Diabetic Nephropathies |
C00001179
|
D003930 | Diabetic Retinopathy |
C00001179
|
D056486 | Drug-Induced Liver Injury |
C00001179
|
D062787 | Drug Overdose |
C00001179
|
D000749 | Anemia, Megaloblastic |
C00001179
|
C538011 | Eales disease |
C00001179
|
D004890 | Erythema |
C00001179
|
D005221 | Fatigue |
C00001179
|
D006029 | Glycosuria |
C00001179
|
D006130 | Growth Disorders |
C00001179
|
D006212 | Hallucinations |
C00001179
|
D006330 | Heart Defects, Congenital |
C00001179
|
D006548 | Hernia, Diaphragmatic |
C00001179
|
D015658 | HIV Infections |
C00001179
|
D006959 | Hyperoxaluria |
C00001179
|
D006965 | Hyperplasia |
C00001179
|
D018798 | Anemia, Iron-Deficiency |
C00001179
|
D006977 | Hypertension, Renal |
C00001179
|
D000740 | Anemia |
C00001179
|
D007037 | Hypothyroidism |
C00001179
|
146850 | IMMUNE SUPPRESSION |
C00001179
|
D007674 | Kidney Diseases |
C00001179
|
D007683 | Kidney Tubular Necrosis, Acute |
C00001179
|
D007859 | Learning Disorders |
C00001179
|
D007945 | Leukemia, Lymphoid |
C00001179
|
D008103 | Liver Cirrhosis |
C00001179
|
D008114 | Liver Neoplasms, Experimental |
C00001179
|
D008171 | Lung Diseases |
C00001179
|
D008175 | Lung Neoplasms |
C00001179
|
D020149 | Manganese Poisoning |
C00001179
|
D008630 | Mercury Poisoning |
C00001179
|
D048629 | Micronuclei, Chromosome-Defective |
C00001179
|
D009120 | Muscle Cramp |
C00001179
|
D000647 | Amnesia |
C00001179
|
D009325 | Nausea |
C00001179
|
D055371 | Acute Lung Injury |
C00001179
|
D009369 | Neoplasms |
C00001179
|
D009374 | Neoplasms, Experimental |
C00001179
|
D009395 | Nephritis, Interstitial |
C00001179
|
D053040 | Nephrolithiasis |
C00001179
|
D009410 | Nerve Degeneration |
C00001179
|
D058186 | Acute Kidney Injury |
C00001179
|
D009765 | Obesity |
C00001179
|
D009845 | Oligospermia |
C00001179
|
D010149 | Pain, Postoperative |
C00001179
|
D010212 | Papilloma |
C00001179
|
D016491 | Peripheral Vascular Diseases |
C00001179
|
D011041 | Poisoning |
C00001179
|
D011230 | Precancerous Conditions |
C00001179
|
D011471 | Prostatic Neoplasms |
C00001179
|
D011507 | Proteinuria |
C00001179
|
D011561 | Pseudoxanthoma Elasticum |
C00001179
|
D011605 | Psychoses, Substance-Induced |
C00001179
|
D011654 | Pulmonary Edema |
C00001179
|
D011657 | Pulmonary Eosinophilia |
C00001179
|
D011658 | Pulmonary Fibrosis |
C00001179
|
D051437 | Renal Insufficiency |
C00001179
|
D012174 | Retinitis Pigmentosa |
C00001179
|
D012614 | Scurvy |
C00001179
|
D005909 | Glioblastoma |
C00001071
|
D012871 | Skin Diseases |
C00001179
|
D011297 | Prenatal Exposure Delayed Effects |
C00004565
|
D013274 | Stomach Neoplasms |
C00001179
|
D010024 | Osteoporosis |
C00004565
|
D007938 | Leukemia |
C00004565
|
D013375 | Substance Withdrawal Syndrome |
C00001179
|
D013921 | Thrombocytopenia |
C00001179
|
D001749 | Urinary Bladder Neoplasms |
C00001179
|
D003921 | Diabetes Mellitus, Experimental |
C00002647
|
D050171 | Dyslipidemias |
C00002647
|
D005234 | Fatty Liver |
C00002647
|
D018149 | Glucose Intolerance |
C00002647
|
D006937 | Hypercholesterolemia |
C00002647
|
D006949 | Hyperlipidemias |
C00002647
|
D015228 | Hypertriglyceridemia |
C00002647
|
D001206 | Ascorbic Acid Deficiency |
C00001179
|
D008546 | Melanoma, Experimental |
C00002647
|
D009069 | Movement Disorders |
C00002647
|
D009361 | Neoplasm Invasiveness |
C00002647
|
D009362 | Neoplasm Metastasis |
C00002647
|
D012516 | Osteosarcoma |
C00002647
|
D010182 | Pancreatic Diseases |
C00002647
|
D000544 | Alzheimer Disease |
C00001429
|
D000648 | Amnesia, Retrograde |
C00001429
|
D001008 | Anxiety Disorders |
C00001429
|
D001022 | Aortic Valve Insufficiency |
C00001429
|
D001049 | Apnea |
C00001429
|
D001281 | Atrial Fibrillation |
C00001429
|
D001321 | Autistic Disorder |
C00001429
|
D001919 | Bradycardia |
C00001429
|
D002389 | Catatonia |
C00001429
|
D002659 | Child Development Disorders, Pervasive |
C00001429
|
D021081 | Chronobiology Disorders |
C00001429
|
D015140 | Dementia, Vascular |
C00001429
|
D003967 | Diarrhea |
C00001429
|
D004195 | Disease Models, Animal |
C00001429
|
D004487 | Edema |
C00001429
|
D005355 | Fibrosis |
C00001429
|
D005483 | Flushing |
C00001429
|
D006349 | Heart Valve Diseases |
C00001429
|
D006930 | Hyperalgesia |
C00001429
|
D006976 | Hypertension, Pulmonary |
C00001429
|
D017379 | Hypertrophy, Left Ventricular |
C00001429
|
D050197 | Atherosclerosis |
C00004565
|
D043183 | Irritable Bowel Syndrome |
C00001429
|
D008944 | Mitral Valve Insufficiency |
C00001429
|
D011537 | Pruritus |
C00001429
|
D020230 | Serotonin Syndrome |
C00001429
|
D013610 | Tachycardia |
C00001429
|
D059246 | Tachypnea |
C00001429
|
D014202 | Tremor |
C00001429
|
D001930 | Brain Injuries |
C00007247
|
D003866 | Depressive Disorder |
C00007247
|